Outcome | Predictor | Non-adjusted model | Adjusted model† | ||
OR (95% CI)* | P value | OR (95% CI) | P value | ||
c-AKI | IGFBP7 | 1.63 (1.14 to 2.33) | 0.008 | 1.97 (1.20 to 3.24) | 0.009 |
NT-pro-BNP | 0.99 (0.97 to 1.01) | 0.45 | 0.99 (0.96 to 1.01) | 0.38 | |
PAPi | 0.68 (0.15 to 3.10) | 0.61 | 0.14 (0.01 to 2.32) | 0.17 | |
AKI | IGFBP7 | 1.29 (1.10 to 1.52) | 0.002 | 1.25 (1.07 to 1.46) | 0.006 |
NT-pro-BNP | 1.00 (0.99 to 1.01) | 0.70 | 1.00 (0.99 to 1.01) | 0.78 | |
PAPi | 0.64 (0.30 to 1.36) | 0.24 | 0.73 (0.38 to 1.41) | 0.35 | |
RVF | IGFBP7 | 1.17 (1.01 to 1.36) | 0.03 | 1.15 (1.00 to 1.32) | 0.06 |
NT-pro-BNP | 0.99 (0.98 to 1.00) | 0.12 | 0.99 (0.98 to 1.00) | 0.14 | |
PAPi | 1.26 (0.51 to 3.10) | 0.61 | 1.21 (0.41 to 3.56) | 0.74 |
*ORs are expressed for an increase of 10 ng/mL for IGFBP7, an increase of 100 pg/mL for NT-pro-BNP and an increase in one unit for PAPi.
†The following variables were used in the risk adjustment: post-induction CVP, mitral or tricuspid valve surgery, diabetes, preoperative creatinine, right ventricular dysfunction and left ventricle ejection fraction.
AKI, acute kidney injury; c-AKI, congestive AKI; NT-pro-BNP, N-terminal pro hormone B-type natriuretic peptide; PAPi, Pulmonary Artery Pulsatility Index; RVF, right ventricular failure.